EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Current treatment options for familial adult myoclonus epilepsy

Antonietta Coppola iD, Raffaele Dubbioso iD, Claudia Cuccurullo, Laura Licchetta iD, Mar Carreno, Edouard Hirsch iD, Leonilda Bilo

Epilepsia · 2023

DOI: 10.1111/epi.17590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2023. Verfasst von Antonietta Coppola und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Reproductive Sciences, and Odontostomatology, Federico II University of Naples, Naples, Italy. Hauptthemen laut MEDLINE: Myoclonus, Epilepsy, Epilepsies, Myoclonic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Università degli Studi di Napoli Federico II.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial adult myoclonus epilepsy (FAME) is a genetic condition characterized by the occurrence of cortical tremor, myoclonus, and epilepsy. To date, there is neither a curative nor a preventive treatment for FAME. Clinical management is essentially symptomatic and based on antiseizure medications (ASMs). The choice of the correct therapeutic option is limited to ASMs that have both an antiseizure and an antimyoclonic effect, such as valproate, levetiracetam, benzodiazepines, and perampanel. However, these medications control seizures well while having a limited effect on myoclonus and cortical tremor. In addition, many ASMs, including sodium channel blockers and gabapentin, are contraindicated in this condition. The ideal therapeutic option would be a precision treatment able to revert the genetic defect underlying it. Nevertheless, this does not seem to be an option that will be available soon.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyoclonusEpilepsyEpilepsies, MyoclonicAdultHumansTremorValproic AcidAnticonvulsants

Stichwörter der Autor:innen

FAMEbenzodiazepinelevetiracetammyoclonusperampanelvalproate

Substanzen

Valproic AcidAnticonvulsants

Autor:innen und Institutionen

  • Department of Neuroscience, Reproductive Sciences, and Odontostomatology, Federico II University of Naples, Naples, Italy.
  • IRCCS Istituto delle Scienze Neurologiche di Bologna, full member of the European Reference Network EpiCARE Bologna, Bologna, Italy.
  • Clinical Institute of Neurosciences, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Epilepsy Unit, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Biomedical Research Institute August Pi i Sunyer, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Epilepsy Unit "Françis Rohmer," French Centre de référence des Épilepsies Rares (CréER), Federation Hospitalo Universitaire, Neurology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

ORCID-Profile: Antonietta Coppola, Raffaele Dubbioso, Laura Licchetta, Edouard Hirsch

Förderung

  • Università degli Studi di Napoli Federico II

Zitieren

APA

Coppola, A., Dubbioso, R., Cuccurullo, C., Licchetta, L., Carreno, M., Hirsch, E., & Bilo, L. (2023). Current treatment options for familial adult myoclonus epilepsy. Epilepsia. https://doi.org/10.1111/epi.17590

Vancouver

Coppola A, Dubbioso R, Cuccurullo C, Licchetta L, Carreno M, Hirsch E, et al. Current treatment options for familial adult myoclonus epilepsy. Epilepsia. 2023. doi:10.1111/epi.17590

BibTeX
@article{Coppola2023,
  author = {Coppola, Antonietta and Dubbioso, Raffaele and Cuccurullo, Claudia and Licchetta, Laura and Carreno, Mar and Hirsch, Edouard and Bilo, Leonilda},
  title = {Current treatment options for familial adult myoclonus epilepsy},
  journal = {Epilepsia},
  year = {2023},
  doi = {10.1111/epi.17590}
}
Kostenlos starten →